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Roma, Italy; and 5Scuola Normale Superiore, Pisa, ItalyABSTRACT The homodimer NGF (nerve growth factor) exerts its neuronal activity upon binding to either or both distinct trans-
membrane receptors TrkA and p75NTR. Functionally relevant interactions between NGF and these receptors have been pro-
posed, on the basis of binding and signaling experiments. Namely, a ternary TrkA/NGF/p75NTR complex is assumed to be
crucial for the formation of the so-called high-affinity NGF binding sites. However, the existence, on the cell surface, of direct
extracellular interactions is still a matter of controversy. Here, supported by a small-angle x-ray scattering solution study of
human NGF, we propose that it is the oligomerization state of the secreted NGF that may drive the formation of the ternary het-
erocomplex. Our data demonstrate the occurrence in solution of a concentration-dependent distribution of dimers and dimer of
dimers. A head-to-head molecular assembly configuration of the NGF dimer of dimers has been validated. Overall, these find-
ings prompted us to suggest a new, to our knowledge, model for the transient ternary heterocomplex, i.e., a TrkA/NGF/p75NTR
ligand/receptors molecular assembly with a (2:4:2) stoichiometry. This model would neatly solve the problem posed by the
unconventional orientation of p75NTR with respect to TrkA, as being found in the crystal structures of the TrkA/NGF and
p75NTR/NGF complexes.INTRODUCTIONNerve growth factor (NGF), the first neurotrophin (NT) to
be discovered, plays a key role in determining survival,
differentiation, and maintenance of specific neuronal popu-
lations during development (1–4). Like other members of
the NTs family, NGF is a functional homodimer composed
of two noncovalently bound chains (5) that exerts its actions
through two structurally unrelated transmembrane receptors
(6–8), the TrkA receptor tyrosine-kinase (9,10), which is
specific for NGF, and the p75NTR receptor (11), a tumor ne-
crosis factor receptor family member that instead is shared
among all NTs.
Each receptor binds independently to NGF with predom-
inantly low affinity, (KD¼ 109 M (9,12–14)), but they pro-
duce high-affinity binding sites (KD ¼ 1011 M) upon
receptors coexpression (12,15).
Such high-affinity binding sites are generally believed to
be crucial for the overall NTs physiology. In fact, induction
of high-affinity binding sites has been characterized on em-
bryonic neurons, not only in the presence of NGF (16)
but also of brain-derived neurotrophic factor (BDNF) and
NT-3 (14,17). Moreover, these sites, in contrast to the
low-affinity binding sites, correlate well with some of the
best known physiological properties of the NTs. Indeed,Submitted July 31, 2014, and accepted for publication November 7, 2014.
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0006-3495/15/02/0687/11 $2.00not only is the half-maximal neuronal survival typically
obtained with NTs concentrations of 5  1012 M, but
they also trigger/mediate special functional and pharma-
cological properties (18–20), ligand selectivity (21,22),
and the differential cross-regulation of TrkA with p75NTR
(23).
Although it is widely accepted that the biologically
active forms of both receptors are the stable and functional
symmetric complexes with NT homodimers (24–26), char-
acterized by a 2:2 stoichiometry, the cross talk mechanism
between TrkA and p75NTR, which originates the formation
of the high-affinity NT binding sites on neuronal cells and
so altering the signaling properties of both partners, is still
poorly understood. To this regard several models of TrkA/
p75NTR complexes have been proposed to produce a site
with high affinity and selectivity for NGF, including: 1)
the ligand passing model, where p75NTR binds NGF and
passes it to TrkA (27); 2) the allosteric model, where inter-
actions between transmembrane and cytoplasmic domains
of both TrkA and p75NTR enhance NGF presentation to the
TrkA and accelerate the rate of association (15,28); 3) the
formation of a transient ternary complex of TrkA/NGF/
p75NTR (12); and 4) a ligand-independent TrkA/p75NTR
heterocomplex, in which a ligand-induced alteration pre-
ludes to the homodimerization of the receptors required
for signaling (29). Even if elusive, the in vivo forma-
tion of a ternary heterocomplex has been supported byhttp://dx.doi.org/10.1016/j.bpj.2014.11.3485
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binding experiments (12), it has been confirmed by affinity
cross-linking and immunoprecipitation studies (30,31).
Nonetheless, the unequivocal functional dissection of the
domains involved in the formation of the high-affinity
binding sites on p75NTR or on TrkA has led to contrasting
conclusions (32–37).
In addition, three recent x-ray crystallographic studies re-
ported evidences against the likely formation of a transient
ternary complex of TrkA/NGF/p75NTR, i.e., the NGF/TrkA
(38,39), NGF/p75NTR (40), and NT-3/p75NTR (26) binary
complexes. The superposition of the structures shows the
ligand binding sites for either receptor are mutually exclu-
sive and therefore not in favor of a ternary heterocomplex
model with a 2:2:2 stoichiometry.
Moreover, the observed opposite orientation of NGF
bound to TrkA as compared to p75NTR cannot be easily
reconciled even with the existence of a 1:2:1 ternary
heterocomplex. Several ad hoc explanations have been
proposed, based on 1) possible multiple proteolytic
cleavages that would trigger the release of the ectodomain
of p75NTR (41,42); 2) likely conformational changes
in the mutual orientations of the different modules of
the TrkA and p75NTR ectodomains (43); and 3) one recep-
tor handing over the NGF ligand to the other receptor
(44).
To solve this conundrum, we now postulate that the
existence in solution of oligomeric forms of NGF may
support an alternative mechanism that would likely
accommodate a transient ternary heterocomplex. Indeed,
NGF oligomers have been previously reported to form
not only in solution, by equilibrium sedimentation studies
(45), but also in the solid state, namely in the crystal
structure of the mouse bis-des-octa beta NGF (mNGF)
bound to zinc Protein Data Bank (PDB) ID 1BTG (46).
In the latter, the potential biological relevance of the
observed dimer of dimers (DD) arrangement was not
considered, ascribing it as a result of artifacts associated
with lattice crystal packing. We therefore sought to
further examine and structurally characterize the oligo-
merization state of hNGF in solution by small-angle
x-ray scattering (SAXS) experiments. The analysis of
our SAXS data demonstrates a concentration-dependent
equilibrium between NGF homodimers and a DD form,
and, in addition, provides structural evidence for a
head-to-head DD assembly of hNGF in solution. This
oligomeric arrangement offers intriguing biological
implications.
Indeed, these findings lead us to hypothesize a tran-
sient ternary heterocomplex with a 2:4:2 stoichiometry
(i.e., TrkA/NGF/NGF/p75NTR), that would reconcile the
observed unconventional orientation of the p75NTR and
TrkA receptors with respect to NGF as well as their mutual
steric obstruction as a result of a simultaneous binding to the
same face of NGF (25,38–40).Biophysical Journal 108(3) 687–697MATERIALS AND METHODS
SAXS experiment and data processing
Synchrotron radiation x-ray solution scattering data were collected on the
X33 beamline (47,48) of the EMBL at DORIS III storage ring, DESY,
Hamburg. Solutions of hNGF, obtained as previously reported (49), in
50 mM Na-phosphate pH 7.0, 1 mM EDTA at 0.43, 1.98, 2.75, 3.77, and
5.5 mg/mL concentrations, were measured using a MAR345 Image Plate
at a wavelength l ¼ 1.5 A˚, covering the momentum transfer range
0.012 < s < 0.45 A˚1. To check for radiation damage two 2-min exposures
were compared; no radiation effects were observed upon addition of 2 mM
DTT to the sample immediately before the measurements. The data were
processed and the scattering of the buffer was subtracted. All data manip-
ulations were performed using the program package PRIMUS (50).
The forward scattering I(0) and the radius of gyration Rg were evaluated
using the Guinier approximation (51) and the program GNOM (52) that
also provides the maximum particle dimension Dmax and the distance dis-
tribution function p(r). The molecular masses of the solutes were evaluated
by calibration against the reference solutions of bovine serum albumin.
The scattering curves from the crystallographic models of hNGF were
calculated using the program CRYSOL (53). For the mixtures of hNGF
the experimental intensity Iexp(s) was represented as Iexp(s) ¼ vd Id (s) þ
vdd Idd (s), where vd and vdd are the volume fractions of hNGF dimers
and DD, respectively Id (s) and Idd (s) are the intensities of hNGF dimers
and DD, respectively. These volume fractions were determined by the pro-
gram OLIGOMER (50) to best fit the experimental data. The shape of
hNGF was reconstructed by the ab initio program DAMMIN (54) employ-
ing simulated annealing to provide a compact interconnected bead model.
The results of multiple runs (15 runs) using the program DAMMIN (53),
were aligned, averaged, and superposed to determine common structural
features using the programs DAMAVER (55) and SUPCOMB (56),
respectively.Modeling, docking, and molecular dynamics
simulations
To obtain an overall molecular model of hNGF, as much as complete, the
crystallographic structure of hNGF from hNGF/TrkA complex (PDB ID
2IFG) (38), missing some residues (underlined in Fig. S1 in the Supporting
Material), was used as template. Its C-term part (A116-A120) was extended
by molecular modeling on the basis of the crystal structure of mNGF (PDB
ID 1BTG) (46) and its missing loop III (P61-S66) was modeled on the basis
of the llama NGF structure (PDB ID 4EFV) (57); the multiple alignment of
hNGF sequence with the two templates is shown in Fig. S1. This model of
hNGF (G10-A120), devoid of the N-terminal region (S1-R9), and the crys-
tal structure of mNGF (G10-R118) were energy minimized and used to
generate the molecular DD assemblies by self-docking with the program
SymmDock (58).
All molecular dynamics (MD) simulations were performed in explicit
water using the GROMACS 4.5 (Groningen Machine for Chemical Simu-
lation) package (59) in conjunction with the Amber99SB force field. The
simple point charge model was used to represent the water. The protonation
state of the ionizable groups of either proteins was chosen according to pH
7.0 and an appropriate number of counter ions were added to achieve charge
neutrality in the simulation system. After energy minimization by using a
steepest descent algorithm, during the equilibration dynamic period the sys-
tem was thermostated to a temperature of 300 K and maintained at a pres-
sure of 1 bar. Starting from these equilibrated structures, MD production
runs of 10 ns in length were performed. All simulations were performed
at 1 atm and 300 K by coupling to an external heat and an isotropic pressure
bath. The MD simulations were aimed 1) at inspecting the structural fluc-
tuations of the reconstructed regions of the hNGF dimer and 2) at investi-
gating the molecular assembly stability association of the selected
solution from the hNGF DD docking.
NGF Dimer of Dimers 689The dynamical behavior of the DD structure was monitored by calcu-
lating 1) the distance between the centers of mass (COMs) of the two di-
mers and 2) the root mean-square derivation (RMSD) using, as the
reference, the starting energy minimized DD assembly.
The DASApolar and DASAapolar upon the hNGF DD formation were
calculated by the program Surface Racer 5.0 (60) with a probe radius of
1.4A˚. The heat capacity change DCp and burial of solvent-accessible sur-
face (DASAapolar and DASApolar) can be correlated according to the
following equations (61,62):
DCp ¼ 1:88 ,DASAapolar  1:09 ,DASApolar;
DHð333 KÞ ¼ 35:30 ,DASAapolar þ 131:00 ,DASApolar:DH(333 K) is defined as the binding enthalpy at 333 K. The latter is the me-dian unfolding temperature of the set of proteins being used for the param-
eterization of the previous relationships, for which thermodynamic and
high-resolution structural information are available (61,62).
All the figures have been created by the program Pymol (63).Biochemical experiments
For analytical gelfiltration experiments, increasing concentration of hNGF
were passed through a Superdex 75 10/300 GL column equilibrated in
50 mM Na Phosphate (pH 7), 1 mM EDTA, 150 mM NaCl at a flow rate
of 0.7 mL/min.
In cross-linking experiments, hNGF stock solution (2.5 mg/mL) was seri-
ally diluted 1:2 and incubated with Bis(sulfosuccinimidyl)suberate (BS3) at
protein/BS3 ratio (mol/mol) of 1/27. These samples were incubated for 24 h
at room temperature to allow cross-linking reactions to proceed. The reac-
tions were terminated by adding sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) sample buffer. To monitor the reaction, the
samples were analyzed by 15% SDS-PAGE in reduced conditions followed
by Coomassie staining.RESULTS
SAXS experiments on hNGF
A pilot set of SAXS measurements was carried out on a
solution of hNGF at a concentration of 5.5 mg/mL. The
experimental pattern and the computed p(r) function are
shown in Fig. S2 A. The derived parameters of molecular
mass of 54 5 5 kDa, Rg ¼ 29.0 5 0.5 A˚ and Dmax ¼
1205 10 A˚ point to a rather extended structure, suggestive
of a DD assembly of hNGF in solution. Remarkably, DD
arrangements were observed in the crystal structure of
mNGF (PDB ID 1BTG) (46). The asymmetric unit consists
of three protomers. Two are related by a twofold noncrystal-
lographic symmetry forming a dimer, whereas the third pro-
tomer forms a dimer by applying a twofold crystallographic
symmetry operation. A close analysis of the crystal packing
clearly showed that the two types of dimers were arranged
as DD. Among the eight DD interfaces, present in the crystal
and assessed with the Protein interfaces, surfaces, and
assemblies service PISA at the European Bioinformatics
Institute (64), the head-to-head DD with the wider interface
area (549.0 A˚2) has been chosen to calculate the scattering
curve, yielding a good fit to our experimental data (c ¼1.88) and confirm the existence of a DD assembly of
hNGF in solution. Moreover the ab initio shape of hNGF
yielded a good superimposition with the previous DD crys-
tallographic assembly of mNGF (46), as shown in Fig. S2 B.Molecular modeling, self-docking, and MD on
hNGF and its assembly
It is worth noting that in addition to differences in the source
of the NGF analyzed by SAXS, human instead of mouse, the
exploited crystallographic structure ofmNGFPDB ID 1BTG
(46) actually refers to the bis-des-octa (1–8) form of mNGF,
the first eight N-terminal residues being removed by proteol-
ysis. Therefore, we resort to obtain a model of hNGF DD
to analyze SAXS data. A structure of partner free hNGF is
however still lacking. To date crystal structures have been
reported for the partner free NGF from mouse PDB ID
1BET (65), 4EAX (66) and 1BTG (46), from cobra PDB
ID 4EC7 (66), and from llama PDB ID 4EFV (57), whereas
hNGF crystal structures have been determined only in com-
plex with the ligand binding domain (d5) PDB ID 1WWW
(39) or the full length of the TrkA receptor PDB ID 2IFG
(38) and of the ectodomain of the unrelated cellular receptor
p75NTR PDB ID 1SG1 (40). A complex of hNGF and the ec-
todomain of p75NTR has also been characterized by solution
x-ray scattering (25). Interestingly, a six residues long loop
(P61-S66), namely loop III, as well as a few residues at the
N- and C-terminals are not defined in the crystal structures
PDB ID 1WWW (39), PDB ID 2IFG (38), and PDB ID
1SG1 (40). The loop III of llama NGF PDB ID 4EFV (57),
whose sequence is nearly identical to hNGF (except for res-
idue 65 that in hNGF is Asp, whereas in llama NGF is Ala),
on the contrary is in one of the two protomers well-defined.
Therefore, we have been able to reconstruct a rather compre-
hensive model of hNGF on the basis of the crystal structures
PDB ID 2IFG (38), PDB ID 1BTG (46), and PDB ID 4EFV
(57). The obtained hNGF model however still lacks the first
N-terminal and the last twoC-terminal residues, respectively.
Energy minimization and subsequent MD simulations using
GROMACS (59) were performed on the resulting model to
validate the structures of the modeled regions and to relax
the main and side-chain conformations of those residues
involved in intermolecular contacts with the TrkA receptor.
As expected, the most flexible regions resulted to be the
loops and the N- and C-termini. However, the 10 ns long
simulation showed that the local structure of the modeled
loop III is not significantly more flexible than the other loops.
The RMS fluctuations, during the 10 ns of MD simulation,
in the Ca position are plotted against the residues of the
hNGF modeled. The N-terminal region of hNGF in either
protomers resulted to be extremely flexible (Fig. 1 A). In
fact, with the only exception of the complex of hNGF with
TrkA (ana-helix is formed upon binding) in all of the remain-
ing complexed and uncomplexed NGF known crystal struc-
tures, the N-terminal residues are not structurally defined.Biophysical Journal 108(3) 687–697
FIGURE 1 MD simulations of hNGF model. (A)
Ca RMS fluctuations over the 10 ns MD simulation
(for clarity only a representative protomer is re-
ported. Nt: N-terminal; I: loopI; II: loopII; III: loop-
III; IV: loopIV; V: loopV; Ct: C-terminal); and of
hNGF DD model: (B) distance between the
COMs of the two dimers, (C) radius of gyration
and (D) RMSD with respect to the energy mini-
mized starting assembly during a 10 ns simulation.
690 Covaceuszach et al.Hence, even though the N-terminal region of hNGF might
play a role in the DD formation, it would be affected by a
local conformational flexibility that is unlikely to be fore-
seen by the clustering methods used to analyze the MD
trajectories. Therefore, we opted to remove residues S1-
R9 from the hNGF modeled structure aiming to increase
the likelihood of native-like poses in the subsequent self-
docking simulations. The energy minimized model of
hNGF, devoid of nine N-terminal residues (S1-R9) was
then subjected to the self-docking simulations to generate
poses of the DD. For validation purposes, the same protocol
was applied to obtain self-docking poses of the mNGF DD
model by using the energy minimized crystal structure of
the bis-des-octa (1–8) mNGF (PDB ID 1BTG) (46), devoid
of 1 N-terminal residue (M9). Furthermore, we aimed to
compare the two self-docking simulations by applying the
same energy and similarity filtering criteria by assuming
that the DD assembly/interface should be conserved across
evolution. The resulting top 100 solutions of each self dock-
ing simulation, performed with SymmDock (58), ranked ac-
cording to a scoring function that includes the geometric fit,
the atomic desolvation energy and the interface area size,
were compared to identify similar poses, and then analyzed
to select those whose shapes were the closest to the head-to-
head assembly observed in the crystal structure of mNGF
(PDB ID 1BTG) (46), that well fitted the experimental
SAXS curve.
The hNGF DD pose ranking 13 among the top 100
solutions (with a geometric score of 10,276, an interface
area size of 1310.40 A˚2, and a desolvation energy ofBiophysical Journal 108(3) 687–69723.86 kcal/mol), showed the lowest RMSD (15.00 A˚),
calculated on Ca atoms, from the reference head-to-head
crystallographic assembly of the mNGF. In addition, this
hNGF DD pose showed to be similar (RMSD 7.04 A˚) to
the third best scored pose among the top 100 solutions of
the mNGF self-docking simulation (with a geometric score
of 11,510, an interface area size of 2138.40 A˚2, and a desol-
vation energy of 59.37 kcal/mol).
The hNGF DD interface was analyzed by the 2P2I
Inspector web-based tool (67). The calculated interface pa-
rameters are within the means and the standard deviations of
interfaces parameters calculated for a nonredundant repre-
sentative data set of homodimeric complexes (for details,
see below).
To assess DD stability, this model was subjected to MD
simulations using GROMACS (59). The distance between
the COMs of each dimer was monitored along the 10 ns
long simulation. The COM-COM distance (Fig. 1 B) re-
sulted to be rather stable from the beginning of the simula-
tion and small fluctuations were observed only for the radius
of gyration (Fig. 1 C). The computed average Rg (along the
10 ns simulation time) of 28.1 5 0.2 A˚ for the hNGF DD
model is very close to the experimental Rg value of 29.0
5 0.5 A˚ (Guinier plot). These results confirm the stability
of the modeled hNGF DD molecular assembly. Moreover,
the analysis of the RMSD calculated on Ca atoms over
time, computed using as reference the energy minimized
starting hNGF DD model (Fig. 1 D), showed that after the
initial stabilization, in the first 2 ns, the assembly did not
considerably deviate from the starting model. Therefore,
FIGURE 2 SAXS experiments on the concentra-
tion dependence of hNGF DD assembly in solu-
tion. (A) The experimental solution x-ray
scattering pattern from hNGF curves (1–5) corre-
spond to solute concentrations (mg/mL) of 5.50,
3.77, 2.75, 1.98, and 0.43, respectively. Dots with
error bars represent the experimental data; solid
lines represent the fits of the experimental scat-
tering curve from a multicomponent mixture
(hNGF dimers and DD) by the program OLIG-
OMER (50). The volume fractions are reported in
Table S1. All the plots display the logarithm of
the scattering intensity I as a function of mo-
mentum transfer s ¼ [4psin(q/2)]/l (A˚1) where
q is the scattering angle and l ¼ 1.5 A˚ is the x-
ray wavelength. The curves are displaced down
by one logarithmic unit for clarity. The p(r) dis-
tance distribution functions calculated from the
experimental SAXS data (dotted line) correspond-
ing to 5.50 mg/mL (curve 1) and to 0.43 mg/mL
(curve 5) are displayed in (B) and in (C), respec-
tively. The p(r) from the hNGF DD and dimer
models (dashed line) are also shown in (B) and in
(C), respectively. The ab initio envelope bead
models for the shapes determination of hNGF (D)
at 5.50 mg/mL (curve 1) and (E) at 0.43 mg/mL
(curve 5). The cartoon (Ca) representations of the hNGF DD (D) and hNGF dimer (E) models, respectively, are superimposed to the envelope bead models
(light blue spheres) obtained by DAMMIN (54). Figure created by the program Pymol (63).
NGF Dimer of Dimers 691the described in silico studies provided comprehensive
models of both hNGF dimers and DD to be used for further
analysis of the SAXS data.FIGURE 3 Concentration dependence distribution between hNGF di-
mers and DD, as assessed by SAXS experiments.SAXS studies on concentration-dependent
assembly of hNGF
SAXS data at 5.5 mg/mL (curve 1 in Fig. 2 A) were analyzed
on the basis of the modeled hNGF DD: the p(r) computed
from the atomistic model of DD (dash line in Fig. 2 B)
well overlaps with the p(r) obtained from the SAXS profile.
The molecular assembly fits well with the shape of hNGF
as determined ab initio from the solution scattering data
by using the DAMMIN program (54) (see Fig. 2 D).
Further SAXS measurements performed on solutions of
hNGF at different concentrations (ranging between 0.43
and 5.5 mg/mL, i.e., 17.2–220.0 mM), showed a significant
concentration dependence of the measured solution scat-
tering curves. Given the intensities from the components
(dimers and DD) OLIGOMER (50) finds the volume frac-
tions by solving a system of linear equations using the algo-
rithm of nonnegative or unconstrained least-squares to
minimize the discrepancy between the experimental and
calculated scattering curves. Details are reported in Table
S1 and in Fig. 2 A (fits from OLIGOMER are displayed as
solid lines). The modeled hNGF dimer provides a good fit
to the data at 0.43 mg/ml (curve 1 in Fig. 2, A and C), it
also well overlaps with the averaged ab initio shape
(Fig. 2 E). The singular value decomposition analysis of
the scattering curves found only two significant singularvalues corresponding to two nonrandomly oscillating singu-
lar vectors (Fig. S3).
The results, plotted in Fig. 3, show that the hNGF DDmo-
lecular assembly appears to dissociate into individual hNGF
dimers at low concentrations (1–2 mg/mL, i.e., 40–80 mM).
These results are in accordance with previously reported
experiments performed on hNGF (~0.3 mg/mL, i.e., 12
mM) by analytical ultracentrifugation (25,26,45). Moreover,
the existence of hNGF DD has also been confirmed by
cross-linking experiments (Fig. 4 A) and gel filtration anal-
ysis. Indeed, in Fig. 4 B, the appearance of a second peak
with a lower retention time corresponds to the DD assembly
(highlighted by an arrow).
When this chromatographic peak has been subjected to a
second run of gel filtration, it dissociates into a homogeneous
peak of purely dimeric hNGF (highlighted by a star),Biophysical Journal 108(3) 687–697
FIGURE 4 Distribution between hNGF dimers
(star) and DD (arrow), as assessed by biochemical
experiments. (A) Cross-linking of serial 1:2 dilu-
tions of hNGF; (B) Gel filtration profiles of
hNGF at different concentrations; mAu values
have been normalized setting 100 the maximum
of each peak for a clearer comparison. (Y,
DD; *, dimers; , protomers).
692 Covaceuszach et al.because of the dilution of the sample. This further confirms
that the DD assembly is concentration dependent in the ex-
ploited range of 0.2–3.8 mg/mL.The concentration-dependent DD assembly of
hNGF is not shared by its precursor form
It is worth noting that the observed hNGF DD arrangement
is restricted to the mature form of hNGF. Indeed, a parallel
SAXS study carried out on the mouse precursor form of
NGF, m-proNGF (amino acid sequence identity 85.06%
proNGF; 89.17% NGF; 80.99% pro-peptide with the human
ortholog), in the concentration range of 3.2–13.0 mg/mL,
i.e., 64.0–260.0 mM, pointed to the only existence in solu-
tion of a dimeric assembly (68,69).
The resulting representative m-proNGF model that was
obtained by the ensemble optimization method according
to the experimental SAXS scattering pattern (69) and
exploiting a structural constraint available from previously
reported H/D exchange experiments (70), explains the
observed different oligomerization behavior between the
mature NGF and its precursor (Fig. 5).FIGURE 5 Mapping the NGF DD interaction surface on the proNGF
model. The prodomains (magenta) hinder the NGF DD interacting surfaces
(yellow) on mature mNGF (cyan). Figure created by the program Pymol
(63).
Biophysical Journal 108(3) 687–697This is likely caused by the direct interaction of residue
W21 with the propeptide region of the m-proNGF (70).
W21 is also part of the interface of the NGF/receptor com-
plex in both TrkA and p75NTR receptors. Remarkably, W21
is engaged in an hydrogen bond mediating DD assembly
(Table 1).
In the proposed model of the hNGF DD, the surfaces
engaged in dimer/dimer interactions encompass residues
located near the N- and C-termini, the loop III and the res-
idues on the surrounding b-sheet regions of the hNGF dimer
(Fig. 2 A): the contribution of the interacting residues to
the stability of the DD assembly was analyzed by PISA
(64) and by the 2P2I Inspector (67). The total interface
area is 2248.70 A˚2. The DASApolar and DASAapolar of
1084.75 A˚2 and 1166.71 A˚2, respectively, represent the
changes in the polar and apolar solvent-accessible surfaces
upon the hNGF DD formation. The energetic calculations
relative to the model of the hNGF DD head-to-head assem-
bly, due to the changes in the solvent-accessible surfaces,
resulted in a DCp and DH(333K) of 0.77 J$K1$mol1
and 100.95 kJ$mol1, respectively.
Overall, 12 stretches of residues are engaged at the dimer/
dimer interface resulting in 254 nonbonded contacts, 6
hydrogen bonds, and 2 salt bridges (Table 1), that involve
either protomers of the two dimers (namely AD and BC).
The secondary structure at the dimer/dimer interface is
mainly b-sheet and it is characterized by 25.0% of chargedTABLE 1 Salt bridges and hydrogen bond interactions across
the interface of the selected model of the hNGF DD molecular
assembly
Dimer AB Dimer CD Distance (A˚)
Salt bridges
A: R69 [NH2] C: D16 [OD1] 2.80
A: R69 [NH1] C: D16 [OD2] 3.10
Hydrogen bonds
A: S19 [N] D: R114 [NH2] 2.80
A: W21 [NE1] D: V117 [O] 2.00
A: R59 [NH1] C: G70 [N] 2.30
A: G70 [NH1] C: R59 [NH1] 2.30
B: R114 [NH2] C: S19 [O] 2.30
B: V117 [O] C: W21 [NE1] 2.00
NGF Dimer of Dimers 693residues. The two interacting protein dimers enclose a vol-
ume of 5474.25 A˚3 (gap volume).
A multiple sequence alignment in UniProt (71) showed
that residues whose side chains are involved in hydrogen
bonds and salt bridges are in NGF from different species
highly conserved across evolution (except for R69 in
distantly related organisms like Danio rerio and Xiphopho-
rus maculatus), suggesting their crucial role in this NGF/
NGF interaction and in NGF activity (data not shown).
Our antiparallel head-to-head hNGF DD model led us to
put forward, to our knowledge, a novel three-dimensional
arrangement for the transient ternary heterocomplex TrkA/
NGF/p75NTR that would reconcile the unexpected incongru-
ity in the crystallographic-derived heterocomplex with a
2:2:2 stoichiometry. In fact, the crystal structures of NGF/
TrkA and NGF/p75NTR (38–40) clearly show not only that
both receptors share a mutually exclusive NGF binding
site but, additionally, that the relative orientations of the
p75NTR and TrkA receptors are opposite with respect to
NGF (Fig. 6 A).
Indeed, the existence of NGF as an antiparallel DD in so-
lution, with the two NGF dimers oriented in a head-to-head
fashion would instead pave the way for a 2:4:2 TrkA/NGF/
NGF/p75NTR heterocomplex (Fig. 6 B), whereby an NGF
DD could neatly be involved in a simultaneous transient
binding to the ectodomains of the TrkA and p75NTR recep-
tors in their native orientations on the cellular surface.DISCUSSION
The initial focus of this study was the characterization of the
oligomerization state of hNGF in solution. SAXS experi-
ments proved that, in solution, hNGF appears mainly as
dimers in equilibrium with tetramers (self-associated DD),
whose distributions are concentration dependent. Further-more, the three-dimensional envelope generated from the
one-dimensional SAXS curves, well supported the occur-
rence of a head-to-head DD assembly in solution. This
unexpected finding posed the question of the biological
function and implications, if any, of the observed hNGF
DD, namely in the context of TrkA/p75NTR receptors cross
talk mechanism and interactions that have been well docu-
mented in the creation of high-affinity NGF binding sites
and signaling modulation (72). Although it is widely
accepted that NGF high-affinity binding sites are generated
by p75NTR and TrkA coexpression, the existence of hetero-
complexes between these receptors being assessed by
in vitro and in vivo bioassays, contrasting evidences have
been reported about which of the receptor domains, i.e.,
the extracellular, the transmembrane, or the intracellular,
participate with the formation of the NGF high-affinity sites.
A recent fluorescence resonance energy transfer study (73)
highlighted a direct physical interaction of TrkA and
p75NTR intracellular domains and suggested that, in a basal
condition, there is a pool of interacting TrkA and p75NTR.
This interaction diminishes as NGF binds and internalizes
TrkAwith a faster kinetics than p75NTR. Furthermore, given
that the superimposition of the NGF/p75NTR (25,40), NT-3/
p75NTR (26), and NGF/TrkA (38,39) structures showed that
the binding sites on the ligands were mutually exclusive, the
possibility of a physical interaction of p75NTR and TrkA
through their extracellular domains was discarded.
On the other hand, the existence in solution of a head-to-
head NGF DD arrangement, as described here, would make
a ternary heterocomplex TrkA/NGF/NGF/p75NTR feasible,
reconciling the available experimental evidences in one
unifying scheme where the extracellular domains of the
receptors play a crucial role in the generation of the high-
affinity binding sites. In this scenario such a transient heter-
ocomplex could take place involving the basal preformedFIGURE 6 Models of the ternary p75NTR/NGF/
TrkA heterocomplex. (A) Model obtained by merg-
ing the individual crystal structures of hNGF in
complex with TrkA (red), PDB ID 2IFG (38), and
p75NTR (blue), PDB ID 1SG1 (40). (B) Model ob-
tained by superimposing the crystal structures of
the individual hNGF complexes with its receptors
on the hNGF DD model validated by SAXS. Figure
created by the program Pymol (63).
Biophysical Journal 108(3) 687–697
694 Covaceuszach et al.homodimers of TrkA and p75NTR receptors, leading to the
observed quick dissociation of the homodimers of the recep-
tors themselves. Indeed, the interaction surface between
the NGF DD is characterized by a less favored binding
enthalpy (100.95 kJ$mol1) compared to TrkA/NGF
(68.69 kJ$mol1) and p75NTR/NGF (61.99 kJ$mol1)
binding enthalpies, that in turn could easily lead to the disso-
ciation of the transient ternary heterocomplex characterized
by a 2:4:2 stoichiometry, leaving each NGF dimer bound to
one of the two engaged cognate receptors and therefore
available for the formation of TrkA/NGF and p75NTR/
NGF symmetric complexes with a 2:2 stoichiometry embed-
ding distinct functional and signaling capabilities.
Interestingly, 63% of the residues encompassing the
oligomeric interface of the hNGF DD model, are conserved
among the human members of the NT superfamily,
being 42% identical, 18% conserved, and 3% semicon-
served. In comparison, the overall amino acid sequences
of the human members of the NT superfamily indicate res-
idues to be 35% identical, 21% conserved, and 4.5%
semiconserved.
It is interesting to note that the less conserved residues
mainly cluster on NGF loop III. This suggests that whether
other members of the NT superfamily would, alike NGF,
form as suggested by Narhi et al. (45) self-associated oligo-
mers, the respective DD assembly may not be necessarily
identical but rather be shaped by the conformation of
loop III and its physicochemical properties (charge, hydro-
phobicity-hydrophilicity). Thus, upon p75NTR binding, a
distinctive binding site would be exposed for the recognition
of the NT by the cognate Trk receptor. This scenario would
indeed take into account the fact that p75NTR enhances Trk
specificities for their cognate NTs (21,22,74).
It is worth noting that, although unconventional, the NGF
DD arrangement closely resembles that being observed in
the crystal structure of FGF1 (fibroblast growth factor) in
complex with its high affinity receptor (FGFR2). The
main difference being a central heparin molecule bound to
two FGF1 ligands recruiting two FGF receptors (75). The
thermodynamics and stoichiometry of the ternary complex
suggested that in solution FGF1 binds to heparin in a trans-
dimeric manner before FGFR recruitment (76).
Even if NGF DDs are observed in solution as a result of
direct protein-protein contacts, as we have showed here,
we cannot exclude that in vivo this interaction might even
be strengthened by means of a matrix component, hence
closely resembling the FGF1 binding to heparin.
A recent carbohydrate microarray study reported com-
pelling evidences on the interactions between a specific
sulfated epitope on chondroitin sulfate, CS-E, and the
NTs, showing that CS is capable of assembling multimeric
signaling complexes and of modulating neurotrophin
signaling pathways (77). In this study, all of the NTs show
concentration-dependent binding to CS-E tetrasaccharides,
with NGF displaying the greatest specificity. Furthermore,Biophysical Journal 108(3) 687–697NGF and BDNF enhance the binding of their cognate Trk
receptor with a selectivity that is greater for the complex
than for the NT alone, whereas NT-3 and NT-4/5 do not
have the same effect on TrkC and TrkB, respectively.
Besides the proposed role of CS polysaccharides in the as-
sembly of NT/Trk receptor complexes, these molecules
might also be involved in an additional level of regulation
by acting on NToligomerization at the cell surface, suggest-
ing that the spatiotemporal expression of CS-E in vivo might
differentially regulate specific NT signaling pathways by
several different mechanisms.
Finally, it is worth noting that the observed NGF DD
arrangement is only restricted to the mature form of NGF,
whereas the precursor proNGF maintains a dimeric assem-
bly (68,69) in the range of the exploited concentrations.
These data point to another significant difference between
the two forms of NGF, which may have profound conse-
quences on their downstream signaling abilities and account
for their distinctive selectivity for the p75NTR coreceptor.
Indeed, on the sole basis of in vitro binding studies (78),
there would be no clear rationale for TrkA not to be a
preferred receptor for proNGF as it is p75NTR, by consid-
ering the in vitro affinities for proNGF of either receptor be-
ing between 15 and 20 nM.
The relevance of the described NGF DD for the in vivo
biological functions of NGF (and, by extension, of NTs)
remains to be ascertained, though such an arrangement
is likely to play a critical role in the sorting process of
NGF for regulatory secretion pathway. Indeed, secretory
granules contain very high (90–150 mg/ml) concentrations
of their secretory products (79–81). In addition, aggrega-
tion, condensation, and loop-mediated homodimerization
(82–85) are known to be crucial for specific segregation
of soluble proteins for the regulated secretory pathway.
In particular, the protein cores of growth hormone and pro-
lactin granules disperse slowly (86,87), insulin crystallizes
in b cell granules (88) and peptide and protein hormones
in secretory granules of the endocrine system aggregate
selectively into amyloid-like cross-b-sheet rich confor-
mation upon prohormone processing (89). Therefore, one
could speculate that NGF oligomerization might be
involved in the sorting process for regulated secretory
pathway being stored in secretory granules as oligomer,
i.e., DD form. Upon secretion the concentration gradient
between the DD and the dimer forms would be affected
by the rate of diffusion and/or by the interactions with ma-
trix component at the level of the cell surface, such as CS
polysaccharides.
Different oligomeric forms of NTs, including the DD,
may also be involved as modulators in the recruitment of
different molecules for synaptic tagging. NTs could be
transported anterogradely from the soma to presynaptic ter-
minals, released as a consequence of neuronal spiking, and
received by the postsynaptic neuron. Conversely, neural or
synaptic activity could led to secretion of NTs from
NGF Dimer of Dimers 695dendrites, and the secreted NTs might act as retrograde fac-
tors on the presynaptic neuron (90,91).
Because NGF is overexpressed in the oxidative environ-
ment linked to neurodegenerative processes (92), this
protein could also be a target for peroxynitrite-mediated
oxidative modifications. Interestingly, the oxidation of
NGF by peroxynitrite in vitro causes nitration (tyrosine
and tryptophan residues) and induces the formation of stable
high-molecular weight oligomers of NGF (93).
In conclusion, we have provided new, to our knowledge,
molecular details on the NGF concentration-dependent olig-
omerization that has not been observed for the unprocessed
proNGF species. The observation that in solution a head-to-
head DD NGF molecular assembly has been detected, likely
to be found also for other NTs, prompts a straightforward
answer to the puzzle of the formation of a transient ternary
heterocomplex between TrkA and p75NTR receptors and
NGF. The proposed model shall pave the way to further
biochemical and biological in vitro as well in vivo experi-
ments that will ultimately prove it or disprove it.SUPPORTING MATERIAL
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